-
1
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
Published 2024-04-01Subjects: “…letermovir; cytomegalovirus; hematopoietic cell transplantation…”
Get full text
Article